Best Wegovy Alternatives in 2026: What to Take Instead, What It Costs, and Who Each One Fits

The best Wegovy alternative for most people is Zepbound — it’s the one FDA-approved weight-loss drug that beat Wegovy head-to-head, with 20.2% average weight loss versus Wegovy’s 13.7% over 72 weeks (SURMOUNT-5, New England Journal of Medicine). Want a pill instead of a shot? Two FDA-approved pills now exist: the Wegovy pill and Foundayo, both starting around $149/month. If the real problem is cost or insurance, check your coverage before you spend anything — a covered GLP-1 can drop to as little as $25 a month with a savings card.

Best Wegovy alternative by your situation

The honest truth is that “best” depends on why you’re leaving Wegovy. Find your row first, then read the full breakdown below.

What are the best Wegovy alternatives right now?

The best Wegovy alternatives are Zepbound (the strongest FDA-approved injectable), the Wegovy pill and Foundayo (the FDA-approved pills for people who want to skip needles), Saxenda (a daily injection when a plan prefers it), and Qsymia, Contrave, or orlistat (lower-cost non-GLP-1 pills). Compounded semaglutide and tirzepatide are a separate category — they are not FDA-approved finished drugs and should not be treated as Wegovy generics.

A quick definition so the rest of this page makes sense. GLP-1 stands for a hormone your gut makes that tells your brain you’re full. Wegovy, the Wegovy pill, Foundayo, Saxenda, and Zepbound are GLP-1 medicines — they copy that “I’m full” signal so you eat less without white-knuckling it. Qsymia, Contrave, and orlistat are also FDA-approved for weight loss, but they work in different ways.

All prices verified June 16, 2026 from each maker or provider. Trial percentages are averages from specific study groups — not a promise of your personal result. Re-check prices before you buy — they move.

Is Zepbound the best Wegovy alternative?

For most adults who want the strongest FDA-approved option, yes — Zepbound is the best Wegovy alternative. In the only head-to-head trial, tirzepatide (Zepbound) produced 20.2% average weight loss versus 13.7% for semaglutide (Wegovy) over 72 weeks. It’s not the right pick if you refuse injections, have a reason you can’t take it, or your plan covers Wegovy but not Zepbound.

Zepbound is tirzepatide, a once-a-week shot that hits two gut hormones instead of one, which is the leading theory for why it edges out Wegovy on the scale.

The proof is strong and recent. In the SURMOUNT-5 trial published in the New England Journal of Medicine in 2025, people on Zepbound lost 20.2% of their body weight versus 13.7% on Wegovy after 72 weeks — about 47% more weight, drug for drug. More than 31% of the Zepbound group lost a quarter of their body weight, compared with 16% on Wegovy. Fewer people quit Zepbound over stomach side effects, too. Full comparison: Zepbound vs. Wegovy.

One more thing that can tip the decision: Zepbound is also FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity. Wegovy is not. If you snore, gasp, or have been diagnosed with sleep apnea, that approval may matter to your doctor.

When Zepbound is not your answer:

• You won’t do injections — pills are in the next section.
• The stomach side effects of GLP-1 drugs are too much for you.
• Your medical history makes it a poor fit — only your clinician can say.
• Your plan covers Wegovy but not Zepbound.
• You’re already on another GLP-1. The label says don’t stack Zepbound with another GLP-1 drug.

On price: Zepbound’s list price is about $1,086 a month, but you don’t have to pay that. Through the maker’s direct program, the starting dose runs $299/month, the next dose $399/month, and the higher maintenance doses $449/month if you refill within 45 days via LillyDirect. Miss the 45-day window and the regular prices apply: $499 for 7.5 mg and $699 for 10, 12.5, and 15 mg. Full breakdown: cheapest Zepbound without insurance.

What’s the best Wegovy alternative if you don’t want injections?

The best no-injection alternative is the Wegovy pill if you want to stay on semaglutide, or Foundayo if you want a pill you can take any time without the empty-stomach routine. Both are FDA-approved and start around $149/month. They trade a little weight-loss power for the convenience of skipping the needle.

Wegovy pill — best if the shot is the problem, not Wegovy itself

The Wegovy pill is oral semaglutide — the same drug family as the Wegovy injection, in tablet form. The FDA approved it in December 2025. In its main trial (OASIS 4, NEJM), people lost 13.6% of their body weight at 64 weeks versus 2.2% on a placebo — and up to about 16.6% for those who took it exactly as directed.

The honest tradeoff: the pill has a strict routine. You take it in the morning, on an empty stomach, with no more than 4 ounces of water, then wait at least 30 minutes before eating, drinking, or taking anything else. Miss that window and it doesn’t absorb well. Price runs $149/month for lower doses up to $299/month for higher doses through Ro and the maker’s pharmacy. More options: how to get the Wegovy pill online.

Foundayo — best if you want a flexible pill

Foundayo (the brand name for orforglipron) was FDA-approved on April 1, 2026. It’s a once-daily pill you can take any time of day, with or without food — no fasting window. In its trial program, people lost around 11–12% of their weight. Price starts at $149/month for the lowest dose. Full pricing: Foundayo cost without insurance.

The honest catch: it’s new. One more thing women should know: Foundayo can make oral birth control work less well, so if you use oral contraceptives, your clinician may have you add a backup method for a month after starting and after each dose increase.

What’s the cheapest Wegovy alternative without insurance?

Among FDA-approved options, the lowest starting prices are the Wegovy pill and Foundayo at about $149/month, and Zepbound from about $299/month — all far below the roughly $1,000–$1,350 retail prices. The single biggest money move is checking insurance first, because a covered copay can drop to as little as $25/month with a savings card.

Here’s the honest cash ladder:

The cheaper, non-GLP-1 route (talk to your clinician about fit):

• Qsymia (phentermine + topiramate) — a daily pill, often cheaper than GLP-1s, with roughly 7–11% average weight loss.
• Contrave (naltrexone + bupropion) — helpful when food cravings are the main battle; roughly 5–9%.
• Orlistat (prescription Xenical, or over-the-counter Alli) — blocks some fat absorption; modest results and, fair warning, messy stomach side effects.

Full cost guide: GLP-1 cost without insurance · Wegovy savings card guide · how to get Wegovy cheap

Are compounded semaglutide and tirzepatide real Wegovy alternatives?

Mostly no — and this is where most articles are out of date. The FDA declared the semaglutide shortage over in February 2025 and the tirzepatide shortage over in December 2024, and the windows for mass-compounding these drugs closed in early-to-mid 2025. Compounded semaglutide is not FDA-approved, the FDA does not review it for safety or quality, and it is not a Wegovy generic. It should only be considered through a licensed pharmacy for a specific, clinician-decided reason.

Two quick definitions. Compounded means a pharmacy mixes the drug itself instead of buying the finished, FDA-approved product from the original maker. 503A and 503B are the two kinds of compounding pharmacies — a 503A makes one batch for one patient’s prescription; a 503B makes larger batches for clinics. Pharmacies were only allowed to mass-produce copies of Wegovy and Zepbound because the FDA had listed those drugs as in shortage.

That shortage is over. Here’s the timeline:

• December 2024 — The FDA removed tirzepatide from the shortage list.
• February 2025 — The FDA removed semaglutide from the shortage list.
• Early-to-mid 2025 — Wind-down deadlines passed for 503A (April 2025) and 503B (May 2025) pharmacies. Making copies of the brand-name drugs was no longer broadly allowed.
• September 2025 — The FDA sent more than 100 warning letters to drugmakers and telehealth companies for misleading claims.
• Early 2026 — The FDA warned 30 more telehealth companies for claiming compounded products were “the same as” approved drugs.
• April 30, 2026 — The FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list. That proposal was still pending in a comment period as of publication.

On safety: As of July 31, 2025, the FDA had received more than 1,150 reports of problems tied to compounded semaglutide and tirzepatide — including people who measured the wrong dose from a vial — and the agency says the true number is likely higher. The FDA has also warned about fake and mislabeled products sold online.

We will never tell you a compounded product is a “generic Wegovy,” is “the same as” Wegovy, or is “clinically proven.” A narrow use still exists: a 503A pharmacy can still make a patient-specific compound when a licensed clinician decides an FDA-approved product genuinely won’t work — say, an allergy to an inactive ingredient. “It’s $99 and I saw an ad” is not a medical reason. For more context: compounded GLP-1 vs. name brand.

Is there a generic Wegovy, or an over-the-counter alternative?

No. There is no FDA-approved generic Wegovy for weight loss, and there is no over-the-counter product equal to it. Compounded semaglutide is not a generic. The only FDA-approved over-the-counter weight-loss medicine is orlistat (sold as Alli), and it does far less than a GLP-1.

A generic is an FDA-approved copy of a brand drug, proven to match it. Semaglutide is still under patent, so no legal generic Wegovy exists yet. Any product calling itself “generic Wegovy” is using the word wrong — usually it’s a compounded version, which the FDA has not reviewed. “Natural Ozempic” supplements aren’t FDA-approved for weight loss and aren’t a real substitute. If you want results in the GLP-1 range, you need a prescription option from the list above.

What should you do if insurance stopped covering Wegovy?

Don’t switch drugs blindly after a denial. First find out why you were denied — it may be missing paperwork, a step-therapy rule, or your plan preferring a different GLP-1, not a flat “no.” Then compare Zepbound, the Wegovy pill, Foundayo, and Saxenda by what your specific plan actually covers, because the cheapest “alternative” is often the one already on your formulary. See our GLP-1 insurance coverage checker.

A denial can actually mean any of these:

• Prior authorization missing — your insurance wants your doctor to prove you need the drug before they’ll pay. The denial just means that form wasn’t filed.
• Step therapy — your plan wants you to try a cheaper option first.
• Missing paperwork on your BMI or a weight-related condition.
• Wegovy is excluded, but Zepbound is covered (or the reverse).
• The shot is excluded, but the pill is covered.
• Your employer dropped all obesity drugs. This one is real and rising — in mid-2025, the pharmacy manager CVS Caremark moved members off Zepbound and onto Wegovy to cut costs. Coverage shifts both ways.

A big change for Medicare in 2026

For years, Medicare Part D didn’t cover GLP-1s for weight loss alone. That’s changing. Starting July 1, 2026, a new program called the Medicare GLP-1 Bridge will let eligible Part D members get Foundayo, Wegovy (shot or pill), or the Zepbound KwikPen for a $50 copay per month, running through December 31, 2027. You have to be in a Part D or Medicare Advantage drug plan, use the drug for weight loss, and meet clinical rules (a qualifying BMI plus conditions like high blood pressure, heart disease, prediabetes, or chronic kidney disease). See our guide: does the Medicare GLP-1 Bridge cover the Wegovy pill?

A few honest notes for government plans:

• Medicaid coverage for weight loss varies by state — only about 13 states covered these drugs for weight loss as of early 2026.
• TRICARE depends on your specific plan and prior authorization.
• Standard commercial cash-pay telehealth and manufacturer savings cards usually don’t apply if you’re on Medicare, Medicaid, or TRICARE — so don’t assume.

Can you switch from Wegovy to Zepbound or the pill?

Yes, but let your prescriber run the switch — timing, side effects, and overlap all matter. The Wegovy label includes a path from the 2.4 mg shot to the 25 mg pill, generally starting the pill about a week after your last injection. And both the Wegovy and Zepbound labels say not to take two GLP-1 medicines at the same time.

Wegovy shot to Wegovy pill: The prescribing information says people on the 2.4 mg injection can move to the 25 mg tablet, starting about one week after the last shot. Your clinician confirms the timing.

Wegovy to Zepbound: There’s no do-it-yourself protocol — ask your prescriber. Don’t overlap the two, watch your stomach as you adjust, and expect your insurance to want a fresh prior authorization. The Zepbound label says don’t combine it with another GLP-1.

Wegovy to Saxenda: Both are GLP-1 drugs, but Saxenda is liraglutide and it’s a daily shot. It’s usually a “my plan prefers it” choice, not a “this is stronger” one — it isn’t.

Is Wegovy HD a different option, or still Wegovy?

Wegovy HD (7.2 mg) is still Wegovy — a higher-dose version of the same drug, not a different alternative. It matters if your problem is a plateau rather than price, coverage, or needles, but it belongs in a dose conversation with your prescriber, not a switch to a new medication.

If Wegovy worked and then stalled, a higher dose may be the answer before you change drugs entirely. Wegovy HD is the highest-strength pen, priced around $399/month self-pay. But don’t assume “more drug” automatically means “more results.” A plateau can also come from dose timing, missed weeks, protein, sleep, or strength training. Sort those out with your clinician first — then decide whether a higher Wegovy dose or a move to Zepbound makes more sense. Guide: how to get Wegovy HD online.

Which Wegovy alternative is right for you?

The best alternative is the one that fixes your specific reason for leaving Wegovy without creating a bigger problem. Cost, needle aversion, side effects, sleep apnea, heart disease, diabetes, and pregnancy plans each point to a different choice. Find yourself here:

If Wegovy is too expensive: Check insurance and prior authorization first. Then compare cash prices on the Wegovy pill, Foundayo, and Zepbound. Only consider non-GLP-1 pills if GLP-1 pricing is still out of reach. Leave compounded for last, and only after reading the section above.

If you hate needles: Wegovy pill or Foundayo. If a non-GLP-1 pill fits you better, that’s a clinician conversation.

If Wegovy stopped working: Before you blame the drug, check the basics — dose, whether you’re taking it consistently, protein, sleep, strength training, and side effects. Then ask whether a higher dose or Zepbound makes sense. See: best GLP-1 for fastest weight loss.

If you have heart disease: Wegovy has a specific FDA approval to lower the risk of heart attack and stroke in adults with known heart disease and excess weight. Zepbound may beat it on the scale, but Wegovy’s heart-risk approval can still make it the right drug for you — your doctor decides.

If you have sleep apnea with obesity: Zepbound’s FDA approval for moderate-to-severe sleep apnea may move it to the front for you.

If you have type 2 diabetes: Ozempic, Mounjaro, and Rybelsus may come up. They’re approved for diabetes, not weight loss alone, so treat them as a diabetes-and-weight conversation. See: best GLP-1 for diabetes.

If you’re pregnant or planning to be: These medicines aren’t for pregnancy. Qsymia in particular must not be used in pregnancy, and the Wegovy label says to stop well before a planned pregnancy because the drug lingers in your body. Talk to your clinician.

When you should NOT choose each option (the dealbreakers)

A trustworthy comparison tells the wrong person to walk away. Each of these medicines has clear reasons it might not be safe or right for you, and knowing them up front saves money, time, and risk. Bring this list to your appointment.

Where to get FDA-approved Wegovy alternatives online

For a Wegovy-alternative search, start with FDA-approved brand-name routes before anything else. Ro is the best first stop because it carries FDA-approved GLP-1s, lists clear pricing, and offers a free insurance coverage checker. Sesame is a strong second choice if you’d rather pick your own doctor and see transparent cash prices.

Why you won’t see compounded providers in this table: because you searched for an alternative to an FDA-approved drug, FDA-approved options come first here. Compounded programs belong in the honest, caveated section above — not in a comparison of legitimate brand-name routes.

What real people say

We won’t put fake reviews on this page. The clearest voice on this whole topic is cost. One long-term patient told NBC News that without a maker’s self-pay program she’d have faced “a tough decision — either I tried to afford $1,000 per month or go without the drug cold turkey after being on it for three years.” That’s the exact fear this page exists to fix — and why we lead with checking coverage before you switch.

On the providers themselves: Sesame holds about 4.5 out of 5 on Trustpilot across roughly 3,900 reviews (Trustpilot notes Sesame invites its customers to leave reviews, so read them with that in mind). Ro is one of the most established names in telehealth, with strong marks for convenience and shipping and common complaints about insurance delays and membership-fee confusion — exactly the catch we flagged earlier.

How we ranked the best Wegovy alternatives

We ranked alternatives by FDA status first, then by the strength of trial evidence, fit for your reason for switching, real cash and insurance costs, clinical support, and clear dealbreakers. Affiliate relationships do not decide FDA status, safety language, or which option ranks above another.

The RX Index is independent guidance for choosing your GLP-1 path. We score providers and treatment routes on what actually matters — clinical legitimacy, care quality, transparency, access, and cost — then help you decide where to start. Here’s the scorecard behind this page:

What we actually verified for this page:

• FDA and DailyMed prescribing info for Wegovy, Zepbound, Foundayo, Saxenda, Qsymia, Contrave, and orlistat.
• FDA statements on the resolved shortages, compounded GLP-1s, and warning letters.
• Published trials: STEP 1 (Wegovy), SURMOUNT-5 (Zepbound vs Wegovy, NEJM), OASIS 4 (Wegovy pill, NEJM), ATTAIN-1 (Foundayo).
• CMS pages on the Medicare GLP-1 Bridge.
• Live pricing pages for Ro, Sesame, LillyDirect, and NovoCare, checked June 16, 2026.

What still needs a fresh check before you buy: every price on this page. Drug prices, promos, and state availability change monthly, and the compounding rule is still being finalized. Note: the $199 Wegovy pen intro price runs through December 31, 2026 only.

Bottom line: which Wegovy alternative should you choose?

Choose Zepbound if you want the strongest FDA-approved option and don’t mind a weekly shot. Choose the Wegovy pill if the needle is the problem. Choose Foundayo if you want a flexible daily pill. Consider Qsymia, Contrave, or orlistat only if a non-GLP-1 route fits you better. And check FDA-approved coverage and cash prices before you ever look at compounded products.

You came here because something blocked you from Wegovy — the price, a denial, the needle, or the nagging feeling there’s a better fit. There is. You’re not wrong to look. The only real mistake is treating every cheaper option as the same kind of medicine. Start with the cleanest FDA-approved route, check what your insurance covers, and widen the search only if you need to.

Frequently asked questions

What is the best alternative to Wegovy?

For most people who want the strongest FDA-approved option, Zepbound is the best alternative to Wegovy, since tirzepatide beat semaglutide head-to-head (20.2% vs 13.7% weight loss over 72 weeks). If your reason for switching is the needle, the Wegovy pill or Foundayo may fit you better.

Is Zepbound better than Wegovy?

For weight loss, the head-to-head data favors Zepbound. But “better” depends on coverage, side effects, comfort with injections, and your health — Wegovy still has a unique FDA approval for reducing heart attack and stroke risk in people with heart disease.

Is the Wegovy pill a real alternative to the shot?

Yes, if your problem is the needle. The Wegovy pill is FDA-approved oral semaglutide. It works, but it has a strict routine: morning, empty stomach, a little water, and a 30-minute wait before anything else.

Is Foundayo a Wegovy alternative?

Foundayo (orforglipron) is an FDA-approved daily pill for adults with obesity, or who are overweight with a related health problem. It’s not semaglutide, and it suits people who want a pill they can take any time without fasting.

Is there a generic Wegovy?

No. There is no FDA-approved generic Wegovy for weight loss. Compounded semaglutide is not a generic and is not the same as Wegovy — the FDA has warned against companies claiming otherwise.

What is the cheapest Wegovy alternative?

Among FDA-approved options, the Wegovy pill and Foundayo start around $149/month and Zepbound around $299/month. With insurance and a savings card, your copay can be as low as $25. Older non-GLP-1 pills can cost less but generally do less.

Is compounded semaglutide a safe Wegovy alternative?

Compounded semaglutide is not FDA-approved and is a different category from Wegovy. Since the shortage ended in 2025, mass compounding is being phased out, and the FDA has reported more than 1,150 adverse-event reports tied to compounded semaglutide and tirzepatide, plus fake products — so it shouldn’t be your default choice.

Will Medicare cover a Wegovy alternative?

Starting July 1, 2026, the Medicare GLP-1 Bridge will let eligible Part D members get Foundayo, Wegovy (shot or pill), or the Zepbound KwikPen for a $50 monthly copay, through December 31, 2027, if they meet the clinical rules. Outside that program, Part D generally doesn’t cover GLP-1s for weight loss alone.

What should I do if Wegovy isn’t covered by my insurance?

First find out why — it may be missing prior-authorization paperwork, a step-therapy rule, or your plan preferring a different drug. A free coverage checker can show whether Wegovy, Zepbound, Foundayo, or another option is covered before you switch or pay out of pocket.

Can I take Wegovy and Zepbound together?

No. Both labels say not to combine them with another GLP-1 medicine. If one isn’t working, the move is to switch under your prescriber’s guidance, not to stack.

Is Ozempic a Wegovy alternative?

Ozempic is semaglutide, like Wegovy, but it’s FDA-approved for type 2 diabetes, not weight loss. It may matter if you have diabetes, but it isn’t a simple swap for weight loss alone.

Is there an over-the-counter Wegovy alternative?

There’s no over-the-counter product equal to Wegovy. Alli (over-the-counter orlistat) can add modest weight loss alongside a low-fat diet, but it’s not a GLP-1 and shouldn’t be compared to Wegovy as an equal.

Can I switch from Wegovy to Zepbound?

A clinician can decide if switching is right, but don’t do it on your own. Zepbound’s label says not to use it with another GLP-1, and your insurance will likely want new approval paperwork.

Related reading

• Zepbound vs. Wegovy: full head-to-head
• Wegovy vs. Zepbound vs. Saxenda
• Best GLP-1 for fastest weight loss
• Best GLP-1 for type 2 diabetes
• How to get the Wegovy pill online
• How to get Wegovy HD online
• Cheapest Zepbound without insurance
• Foundayo cost without insurance
• Wegovy savings card guide
• How to get Wegovy cheap
• GLP-1 cost without insurance
• GLP-1 insurance coverage checker
• Compounded GLP-1 vs. name brand
• Best brand-name GLP-1 via LillyDirect
• Does the Medicare GLP-1 Bridge cover the Wegovy pill?

Sources

1. FDA — FDA’s concerns about unapproved GLP-1 drugs used for weight loss
2. FDA — FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
3. FDA — FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s
4. DailyMed / Drugs@FDA — prescribing information for Wegovy, Zepbound, Foundayo, Saxenda, Qsymia, Contrave, and orlistat.
5. New England Journal of Medicine — SURMOUNT-5: tirzepatide vs semaglutide (20.2% vs 13.7%)
6. New England Journal of Medicine — OASIS 4: oral semaglutide 25 mg (−13.6% vs −2.2%)
7. Eli Lilly — Foundayo FDA approval (April 1, 2026); LillyDirect Zepbound self-pay pricing
8. Novo Nordisk / NovoCare — Wegovy pen and pill pricing (verified June 16, 2026).
9. CMS — Medicare GLP-1 Bridge
10. Ro — GLP-1 pricing and free GLP-1 Insurance Coverage Checker (verified June 16, 2026 at ro.co).
11. Sesame — Success by Sesame pricing and medication menu (verified June 16, 2026).

Medical disclaimer: This page is for information only and is not medical advice. Decisions about starting, stopping, switching, or dosing any medication — and whether you qualify — must be made with a licensed clinician.

The RX Index is an independent guide. We are not the manufacturer or pharmacy for any medication discussed. Verify all prices and program terms on the provider’s site before purchasing. Medication approvals, prices, and program details can change; we last verified this page on June 16, 2026.